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Although surgery is still the most important treatment
modality in the management of head and neck cancer,
radiotherapy (XRT) is increasingly being used, either as
(neo)adjuvant therapy or as primary treatment with or
without concurrent chemotherapy.1,2 Despite significant im-
provements in reconstructive (micro)surgery over the last
years, which have made more extensive tumor resections
feasible, about two thirds of patients still require adjuvant
XRT or concurrent chemoradiotherapy to improve oncologic
outcome.2 Consequently, the majority of patients with head
and neck cancer are at risk of developing osteoradionecrosis
(ORN) of the jaws as a complication of XRT.
ORN is themost serious and important complicationofXRT. It
was defined byMarx in 1983 as the presence of exposed bone in
an irradiated field that fails to heal within a 3-month period.3
The reported incidence of ORN in literature ranges from 0.9 to
35%.However, a recent large retrospective reviewof 830patients
with head and neck cancer who received XRT in a 30-year time
period showed an 8.2% incidence of ORN of the jaws.4
Etiology, Pathophysiology, and Prevention
of ORN
Etiology
ORN is one of the late complications after XRT. The most
common location for ORN is the mandible, most likely
because of its relatively poor vascularization.2,4 Early-stage
ORN, within 2 years of XRT, is thought to be a result of a high
radiation dose (>70 Gy) and/or associated surgical and/or
radiation trauma. Late-stage ORN, several years after XRT, is
often secondary to traumawithin the devitalized tissues such
as intraoral surgery.2,4
Pathophysiology
The pathophysiology of ORN seems to be a damaged micro-
vasculature as a result of radiation induced endarteritis,
thrombosis, and obliteration of vessels. In addition, the
production of free radicals as a detrimental consequence of
XRT impairs the ability of the bone to repair and remodel.
Secondary lesions of these hypoxic tissues may then lead to
infection of the previously weakened bone and soft tissues
and to the development of a chronic, nonhealing wound.4
These effects of XRT were described by Marx as the “3 H’s”:
hypocellularity, hypoxia, and hypovascularity.2,3,5
More recently, another theory has been proposed stating
that suppression of osteoclast-related bone turnover is the
initial damage of the destructive ORNprocess. The underlying
concept explains that osteoclasts sustain radiation damage
prior to the development of vascular changes. It seems that
“bisphosphonate-induced osteonecrosis” of the mandible
supports this concept, as bisphosphonates also inhibit
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Abstract Although surgery still is the most important treatment modality in the management of
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majority of head and neck cancer patients are at risk of developing osteoradionecrosis of
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aesthetic outcome after surgical treatment for osteoradionecrosis are discussed.
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osteoclast-mediated bone resorption and can result in
osteonecrosis.6
A wide range of risk factors that contribute to the devel-
opment of ORN have been described.2,4–7 They can generally
be divided into tumor-, patient-, or XRT-related risk factors.
Tumor-related risk factors include tumor stage and size, the
anatomical location, and the degree of involvement of neigh-
boring bone structures. Patient-related risk factors include
poor oral hygiene, periodontitis, extensive caries, and den-
toalveolar surgery during XRT or in the early postoperative
period. Alcohol consumption and smoking may also contrib-
ute to the development of ORN. XRT-related risk factors are
the total dose delivered (increased risk>60 Gy, varying in the
literature), dose fractionation (increased risk with fraction
sizes >2 Gy), the size of the irradiated area, and the type of
XRT used (brachytherapy or external beam irradiation).
Prevention
Prevention of ORN is of pivotal importance; hence, the risk
factors mentioned earlier should be addressed whenever
possible. Establishment of effective oral hygiene is very
important, and every patient should have a full dental
evaluation prior to XRT, including prophylactic oral care
before, during, and after completion of XRT.2,5,6 All diseased
teeth have to be extracted, optimally 2 to 3 weeks before
starting XRT. All patients should be educated on meticulous
oral hygiene and instructed to rinse with a fluoride and
antibacterial mouthwash on a regular basis. All patients
should have close follow-up by their dentist to ensure
compliance.
Advances in the delivery of XRT are promising in reducing
the incidence of ORN. Intensity-modulated radiotherapy
(IMRT) and three-dimensional (3D) conformational XRT are
two of these promising XRT protocols. Multiple studies have
shown reduced incidence rates of around 6% with the use of
these newer XRT techniques.6,8–10 One study even reported
the absence of ORN in 176 patients treated with IMRT and a
median follow-up of 34 months.11 According to the inves-
tigators this could not only be attributed to the use of IMRT,
but also to meticulous oral hygiene and salivary gland
sparing.
Diagnosis and Classification of ORN
Diagnosis of ORN is primarily based on clinical findings and
patient history.5,12 ORN can manifest itself months to even
years after irradiation of the area and usually starts with a
nonhealing ulcer, eventually leading to exposure of necrotic
bone. Secondary infection of the hypoxic tissues can cause
severe pain with chewing or swallowing difficulties. In more
progressed stages of ORN, bone sequestration can occur aswell
as trismus, orocutaneous fistula formation, local or systemic
infection, and pathological fractures. Although the mucosal
lesions may appear small, imaging techniques usually show
more extensive underlying damage. Hence the combination of
both computed tomography (CT) and magnetic resonance
imaging (MRI) scanning can allow early diagnosis of ORN
and can assist in visualizing the extent of ORN.
Staging
A few clinical staging systems for ORN have been proposed by
different authors, but only that of Marx has been widely
used.13 It is based upon response to therapy and consists of
three stages.2 Problems with this staging system are that it is
related to the use and response to hyperbaric oxygen (HBO)
therapy, rather than to the pathophysiology of ORN itself, and
that the disease cannot be staged before the treatment plan
has been established and initiated.
Epstein et al tried to improve the classification of ORN in
1987 by describing the activity of the disease.12 Stage I is
defined as healed, resolved ORN. Stage II includes patients
with chronic (>3months), persistent but stable ORN. In stage
III, patients have symptoms of progressive, active ORN. All
three stages are subdivided in (a) “absence of pathologic
fractures” and (b) “presence of pathologic fractures.”
In 2002, Kagan and Schwartz again tried to improve the
classification of ORN.14 In their three-stage system the disease
is classified based on clinical and radiologic findings, and
treatment is based on the stage. Stage I includes minimal
soft-tissue ulceration and limited exposed cortical bone. These
patients are treated conservatively. Stage II includes localized
involvement of the mandibular cortex and underlying medul-
lary bone. Themajority of patients in this stage are also treated
conservatively or are treated with minor surgical procedures.
Stage III includes full thickness involvement of the bone,
including the inferior border. Pathological fractures may be
present. All patients in this stage require surgical treatment,
including bone and/or soft-tissue replacement. Stage II and III
are subdivided into (a) and (b), where (a) stands for minimal
soft-tissue ulceration and (b) represents the presence of an
orocutaneous fistula and mild soft-tissue necrosis.
Treatment—Conservative Management
In the early stages of ORN, when there is just a single small
lesion, conservative management can be considered. Usually
this consists of pain relief and treatment of infection with
antibiotics. Small wounds may also be debrided superficially
and loose necrotic bone may be removed. Over half of these
early-stage lesions can be cured in this manner.2,5
Recently, new treatment possibilities have been proposed,
such as the antioxidant agent pentoxifylline (PTX), a deriva-
tive of methylxanthine. It produces an anti–tumor necrosis
factor-α effect, facilitates microcirculation, and inhibits in-
flammatory mechanisms, fibroblast proliferation, and the
formation of extracellular matrix.5 It is used in the treatment
of intermittent claudication and has been used in radiation-
induced soft-tissue damagewith some success, but its efficacy
in ORN is still controversial.2 In addition, a synergic effect has
been observed between PTX and tocopherol (vitamin E) in the
treatment of ORN. Delenian et al administered to 54 patients
prolonged treatment for ORN that involved a PTX dose of 800
mg/day and tocopherol 1000 IU/day (5 days a week) and
observed an 89% reduction in bone exposure after
12 months.15
HBO therapy is another nonsurgical treatment modality
for ORN. However, because there is still a shortage of
Journal of Reconstructive Microsurgery Vol. 29 No. 2/2013
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conclusive evidence, the controversy of this treatment still
remains and the discussion is ongoing. The use of HBO
therapy is based on Marx’s theory that ORN is a result of
the “3 H’s.” HBO is thought to increase the blood-tissue
oxygen gradient, improving the diffusion of oxygen in hyp-
oxic tissues, which in turn stimulates repair processes such as
osteogenesis. It also improves angiogenesis by increasing the
expression of growth factors such as vascular endothelial
growth factor (VEGF).5,6
HBO therapy can either be used therapeutically, in early
stages of ORN, prophylactically to prevent ORN from devel-
oping, or in addition to surgical treatment. In accordancewith
Marx’s original protocol, therapeutic use of HBO therapy is
advised to consist of 30 HBO dives to 2.4 atmospheres for 90
minutes. Good responders should continue to a total of 40
dives. Patients planned for more radical surgery, or patients
facing preventative measures such as dental extractions, are
advised to have 20 dives preoperatively followed by 10 dives
postoperatively.16 Although HBO therapy seemed to be very
effective in Marx’s original studies, more recent studies
showed less positive effects.17–21 Annane et al found in a
prospective randomized controlled study during an interim
analysis that patients treated with HBO (n ¼ 31) even fared
worse comparedwith patients in the placebo arm (n ¼ 37).17
Therefore, the study was terminated beforehand. In a recent
review on the efficacy of HBO therapy for ORN the authors
concluded that according to new understandings of the
physiopathology of ORN and according to the best evidence
from high-quality randomized controlled trials, HBO therapy
should not be recommended in the routine management of
patients with mandibular ORN, except when resection and
reconstruction surgery is needed.22
Treatment—Nonmicrosurgical Management
In the more advanced stages of ORN and in cases where
conservative measures failed, surgical treatment is required.
First, a possible local recurrence of a malignancy should be
excluded via a biopsy.2 The study by Hao et al showed that in
21% of their studied population (n ¼ 33) the diagnosis of ORN
was later changed in recurrent cancer after taking a biopsy.23
Therefore, some experts think that surgical treatment for
ORN should be as radical as primary tumor surgery. Further-
more, a CT-scan or MRI should be made preoperatively to
assess the margins of resection. Still, the definite extent of
resection can only be determined intraoperatively with mar-
gins that show healthy, bleeding bone.21,24
As Marx described in his stage III ORN, the more advanced
stages could be managed by performing a sequestrectomy in
combination with bony stabilization with a reconstruction
plate after an initial HBO treatment of 30 dives. Immediate
soft-tissue coverage is obtained by using a pedicled myocuta-
neous flap, as primary closure is usually impossible. Usually a
regional pedicled flap, such as the pectoralis major myocuta-
neous flap, is used, but the latissimus dorsi, trapezius, or
sternocleidomastoid flapmay also be used in particular cases.2
About 3months later bony reconstruction is performed using a
nonvascularized bone graft. Some current literature advocates
that the patient should receive 10 HBO sessions after initial
sequestrectomy, before planning the bony reconstruction and
flap coverage approximately 10 to 12 weeks later.2,25
Treatment—Microsurgical Reconstruction
Most experts feel that the availability of reconstructive
microvascular surgery has made Marx’s algorithm of preop-
erative HBO followed by resection and delayed nonvascular-
ized bone graft reconstruction outdated and of questionable
efficacy.2 It has been generally accepted that wide, radical
resection of necrotic bone with immediate free flap recon-
struction is often the only and best option for the treatment of
advanced ORN.2
Reconstruction Goals
Bony reconstruction of the mandible has presented multiple
problems in the past with low success rates and high mor-
bidity.26 The mandible contributes to airway stability and is
important inmastication, deglutition and speech. In addition,
it largely determines the shape of the lower face. Consequent-
ly, these functional and aesthetic qualities of themandible are
the specific goals in mandible reconstruction and are all
equally important.24 Important functional goals include pres-
ervation of tandem temporomandibular joint action with
maximal opening ability and maintenance of occlusion. Sym-
metry, preservation of lower facial height and anterior chin
projection, and correction of submandibular soft-tissue neck
defects are the main aesthetic goals.
Free Flap Choice
A few criteria are essential in the preoperative planning for
microsurgical reconstruction after ORN. The first criterion is
the necessity for sufficient amount of bone stock for recon-
struction of the mandible or maxilla. Second, the soft-tissue
paddle of the selected free flap should also be sufficient, as
often there is considerable soft-tissue loss as well. Finally, the
vessels of theflap should be of sufficient diameter and length,
because often there are no suitable recipient vessels in the
neck due to previous surgery and XRT. Usually, recipient
vessels outside the radiated area have to be selected, such
as the transverse cervical or thoracoacromial vessels.27–29
Osteofasciocutaneous Free Flaps
Radial Forearm Flap
The radial forearm flap has a relatively constant and repro-
ducible vascular anatomy with long and large vessels. It can
also be raised as an osteofasciocutaneous flap incorporating a
segment of the distal radius, although the height and bone
stock are limited. This makes the flap suitable for selected
maxillary defects.30 Other advantages are the presence of
both a superficial and deep venous system and the versatility
in flap design.31–33
Disadvantages are the risk of a fracture when harvesting
bone (for which prophylactic plating is suggested) and the
need for sacrificing a major artery in the arm, which can
compromise the vascular supply of the hand.30,31
Journal of Reconstructive Microsurgery Vol. 29 No. 2/2013
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Scapula Flap
The scapula flap is a reliable flap with a consistent vascular
pedicle of sufficient length and caliber. Because it is possible
to harvest this flap as a true chimera flap including multiple
tissues (skin, fat, muscle, and bone) supplied by one vascular
pedicle, its popularity for reconstruction of ORN defects is
increasing. Another advantage is the minimal functional
shoulder morbidity after harvesting this flap.34 In addition,
skin color match with the head and neck area is better
compared with other more distant flaps, and in most indi-
viduals it includes non-hairbearing skin.34
Disadvantages include the possible need for additional skin
grafting to close the donor area and the position of the patients
(prone or lateral decubitus), which could jeopardize a conve-
nient reconstruction of the mandible and soft tissues.34
Fibula Flap
Compared with other flaps, the fibula flap is superior regard-
ing bone length and vascularization. A long single bone
segment up to 26 cm in adults can be harvested, but for
most bony head and neck defects multiple osteotomies are
preferable to allow contouring. The resulting short fibula
segments are vascularized by segmental circular arterial
branches originating from the peroneal artery. Therefore, it
has become one of the most commonly used vascularized
osteofascio(myo)cutaneous flaps. The fibula flap may also
contain muscle (flexor hallucis longus and/or soleus), overly-
ing fascia and, if necessary, skin. In contrast to the iliac crest
flap, the skin paddle can be designed and inset in a more
versatile manner and can therefore create an aesthetic and
functional more rewarding result.
Usually, patients have very little donor-site problems;
however, possible complications are limited ankle function
and discomfort, flexor hallucis longus contractures, skin graft
failure, and displeasing donor site scarring.35–37
Iliac Flap
One of the most common applications of the iliac flap is
mandibular reconstruction, because of its generous amount
of cortical and cancellous bone and curved shape.25 The flap
can provide a bone segment with a total length of 16 cm. It is
essential to create a mandible-like shape, and a minimum
height of 2 cm is advised for optimal mandibular reconstruc-
tion. The flap is supplied by the deep circumflex iliac vessels.
Aside from the bone, a skin and/or muscle paddle can be
included for soft tissue reconstruction.
Flap dissection can be lengthy and tedious, and theflap has
a rather thick and immobile muscle and/or skin paddle that
may be too bulky for intraoral soft-tissue reconstruction. In
addition, serious donor-site problems such as abdominal
contour deformity, herniation, lack of sensibility, painful
neuropathy, gait disturbance, and the need for mesh rein-
forcement after harvest of a bicortical bone flap have been
reported to occur in 10 to 25%.25
Soft-tissue only Free Flaps
To provide bone continuity, a bone flap is the most favorable
flap formandible reconstructions. However, this is not always
necessary, as bone reconstruction is particularly important in
anterior mandible defects. ORN often involves the lateral or
posterior body of themandible, inwhich bone reconstruction
is less essential.38,39 Kroll et al evaluated 854 free flaps for
oncologic reconstruction and concluded that bone flaps were
nearly five times more likely to fail than soft-tissue only
flaps.40 Therefore, using a soft-tissue only flap to fill the
mandible defect, such as an ALT flap or a rectus abdominis
flap, can lead to a satisfactory outcome. Functional and
aesthetic outcome of soft-tissue versus bone flaps has not
yet been studied well; however, Baumann et al showed no
significant difference in their study evaluating outcome of
free flap reconstruction in ORN patients (n ¼ 63).38
Rectus Abdominis Free Flap
The rectus abdominis is a reliable flapwith lowmorbidity and
low complication rates.41 Itsmain advantages are the relatively
easiness to harvest, the large caliber vessels, and the relatively
large pedicle.40,41 Kroll et al reported that rectus abdominis
flaps had a significantly lower failure rate (0.9%) than all other
flaps used (6.6%), and also that the vascular thrombosis rate
(2.5%) was significantly lower compared with other flaps
(7.8%).40 However, after using this soft-tissue only flap, a loss
of definition at the angle of the jaw and no functional tempo-
romandibular joint (TMJ) at the side of the defect will occur.
Dental implants are no option without having mandible re-
construction, and dental occlusion will be imperfect.39
Anterolateral Thigh Flap
Advantages of the ALT flap are multiple. It has a large vessel
size and long vascular pedicle to facilitate anastomosis, and
because the lateral femoral cutaneous nerve is included in the
flap, it can potentially be a sensate flap. The vastus lateralis
muscle can be included in this flap to gain more soft-tissue
volume, and the thickness of this flap can be adjusted and
thinned as well.42 It has a large cutaneous area, and the donor
site can usually be closed primarily if the width is less than 6
to 8 cm. Donor-sitemorbidity usually isminimal.43Moreover,
while harvesting this flap, there is no need for positional
changes and it can be harvested simultaneously using a two-
team approach.
Double Free Flaps
According to Urken et al, soft-tissue reconstruction has an
equal or even greater effect on functional outcome than bony
reconstruction, and soft-tissue volume deficiency is poorly
tolerated in the head and neck area.44 Fluids may accumulate
in nonobliterated dead spaces that may lead to secondary
infections, threatening flap survival. Dead spaces often con-
tract, leading to a sunken appearance causing difficulties in
speech, swallowing, and chewing. For watertight intraoral
closure, sufficient soft tissue should be available to prevent
salivary contamination, which can also jeopardize flap sur-
vival.45,46 Because the soft tissues attached to an osseous free
flap are not always large and mobile enough to reconstruct a
composite through-and-through defect of the mandible, a
second free flap is sometimes necessary for adequate recon-
struction. It allows easier insetting and better reproduction of
Journal of Reconstructive Microsurgery Vol. 29 No. 2/2013
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the 3D anatomic boundaries. Still, according to a study byWei
et al, double free flaps were only indicated for mandibular
reconstruction in 18% (36 of 201 composite mandibular
defects) in which ablative surgery was performed for ad-
vanced buccal carcinoma.46 Andrades et al performed double
free flap reconstructions of the mandible in only 5% in more
than 1000 free flap head and neck reconstructions.47 Indica-
tions for double free flaps were (1) extensive skin resection or
presence of radiodermatitis in the neck that had to be excised;
(2) extensivemucosal resection/removal of soft palate, lateral
pharyngeal wall, part of the tongue and floor of the mouth,
pterygoid fossa dissection, and inferior maxillectomy leaving
the maxillary sinus open; (3) large mandibular bone defects
with substantial loss of the overlying and underlying soft
tissues; and (4) anticipation of difficult insetting with a single
free flap because of the extent and tridimensional nature of
the defect.46
Other authors agreed that double free flaps have proven to
be useful, but only in extensive mandibular defects, as the
procedure is surgically challenging and the patients’ condi-
tion is usually poor. Therefore, local complication rates are
often higher, and aesthetic and functional outcomes (speech,
swallowing) are usuallymodest.45,47–49 There is also the need
for two sets of recipient vessels in the neck, which can be
extremely challenging to find in previously irradiated pa-
tients. The second flap can also be connected to the distal
offspring of the first flap; however, this is not preferable, as
occlusion in one flap can lead to the loss of both flaps.49
The fibula osteoseptocutaneous flap is mostly used in
combination with a second soft-tissue free flap—such as the
radial forearm, the ALT, or the rectus abdominis flap—to
restore the massive soft-tissue loss. In 1999 Wei et al pre-
ferred using the fibula osteoseptocutaneous-radial forearm
flap combination (20/36) in their series of 36 double free flap
mandible reconstructions, followed by the fibula osteosepto-
cutaneous-rectus abdominis myocutaneous free flap combi-
nation (11/36). Later, with the increasing popularity of the
ALT flap, a shift wasmade to the fibula osteoseptocutaneous–
ALT flap combination (64/130), followed by the fibula osteo-
septocutaneous–radial forearm flap (20/130), and the fibula
osteoseptocutaneous–rectus abdominis flap (15/130).46,50
Nowadays, more authors seem to prefer the use of the fibula
osteoseptocutaneous-ALT flap combination48,49,51 however,
the radial forearm flap is still a popular alternative.47
Recipient Vessel Selection
Using free flaps is challenging in patients who had previous
surgery and/or XRT due to the depleted amount of blood
vessels, resulting in longer operating times and the need for
additional incisions or harvesting of vein grafts.27,29,50 Nev-
ertheless, usually microsurgical reconstruction is still feasible
in these “frozen” necks.27,28 Often the standard recipient
vessels as the facial, lingual, and superior thyroid vessels
are not available anymore. Therefore, the external carotid,
transverse cervical, thoracoacromial, or internal mammary
arteries usually have to be selected. The internal or external
jugular, transverse cervical, cephalic, or internal mammary
veins are mostly used for venous drainage in these recon-
structions.27,28,52 Use of vein grafts is sometimes inevitable
but leads to increased microsurgical complication rates.53–55
Optimizing Outcome
Complications
Surgical management of patients with ORN is complex and
challenging, because of irradiation and previous surgery,
which respectively cause wound healing problems and oblit-
eration of tissue planes. ORN patients also have a higher risk
of developing carotid artery atherosclerotic lesions, and in
patients with previous free flap reconstruction, the choice of
recipient vessels may be limited.24Major postoperative com-
plications that require surgical intervention occur from 0 to
32%.17,24,56 In 0 to 14%, these major complications lead to
partial or total free flap loss, which requires a second free flap
or regional myocutaneous flap.7,17,24,56,57 In double free
flaps, major complications rates of 30 to 50% are reported,
with the same rate of flap survival compared with single free
flap reconstructions (93 to 100%).49 Minor complications,
such as donor-site wound healing problems, infection, and
orocutaneous fistula formation, occur in 8% to 30% of cases in
the current literature.7,17,24,57,58
Baumann et al divided ORNdefects in two groups: patients
with simple mucosal defects and patients with complex
through-and-through defects.38 In their series, patients
with complex defects had a complication rate of 39% (15 of
38), whereas patients with simple defects had a complication
rate of 20% (5 of 25), although this difference was not
statistically significant (p ¼ 0.17). Within these groups,
bone reconstructions were compared with soft-tissue only
reconstructions. In patients with complex defects, the com-
plication rates were significantly higher (p ¼ 0.02) after the
use of bone flaps (54%; 13 of 24) than after soft-tissue only
flaps (14%; 2 of 14). However, in patients with simple defects
these differences did not reach statistical significance
(p ¼ 0.29), most likely due to the small sample size.
Tumor Recurrence and Patient Survival
Tumor recurrence rates after ORN reconstructions range from
0% to 25% in literature, with a maximum follow-up time of
62months. Patient survival rates, not necessarily disease free,
are usually around 70 to 80%with the samemaximum follow-
up time.24,56–58
Functional and Aesthetic Outcome
Studies on functional and aesthetic outcome after ORN are
scarce. Baumann et al reported functional outcome of free
flap reconstructions following ORN in 63 patients.38 In their
series, 57% of patients could tolerate an oral diet, 26% required
tube-feeding supplementation, and 16% were tube-feeding
dependent at the time of their last follow-up. Mean follow-up
was 18.2 months (range 3 to 72 months). The incidence of
tube-feeding dependence was similar after bone and soft-
tissue only flap reconstruction. In patients with complex
through-and-through defects, a higher incidence of tube-
feeding dependency was seen (24%) than in patients with
Journal of Reconstructive Microsurgery Vol. 29 No. 2/2013
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simple defects (4%), although the difference was not statisti-
cally significant (p ¼ 0.073).
Cordeiro et al reported long-term functional and aesthetic
results of 133 fibula free flap reconstructions, of which only 8
were ORN cases.30 In this series, return to an unrestricted diet
was seen in 45% of patients, 45% were able to eat a soft diet, and
5% were on a liquid diet. The other 5% required tube feeding.
Speechwasnormal tonear normal in63%, intelligible in28%, and
unintelligible in 9%. Aesthetic outcome was good to excellent in
59% of patients, fair in 27%, and poor in 14%. In general, patients
with lateral and hemimandibular defects had better speech and
aesthetic outcome than did patients with central defects.
Double free flap reconstructions have a poorer long-term
aesthetic and functional outcome. Posch et al objectively scored
function at follow-up (mean 3 years and 1 month) and found
problematic speech, impaired deglutition, and oral inconti-
nence in five, two, and four out of six patients, respectively.49
Aesthetic results were subjectively scored as good by three
patients, neutral by one patient, and poor by two patients.
Objective evaluation of aesthetics showed mainly color mis-
match of external flaps (4/6), flap contracture of external flaps
(3/6), flap bulkiness (2/6), and sagging of the flap (1/6). Some
patients had more than one of the above. These somewhat
disappointing results are similar to those of Gabr et al,45 but
Jeng et al48 and Wei et al46 reported somewhat better results.
Dental Rehabilitation
Few patients receive osteointegrated dental implants after ORN
reconstruction. There is limited evidence in literature that
implants placed in the reconstructed areas have success and
survival rates comparable to those obtained in case of implants
placed in native bone.59,60 In the series of Chiapasco et al, 16 out
of 59fibula freeflap reconstructions received a total of 72dental
implants.59With amean follow-up of 50.2 months (range 24 to
96 months), their cumulative success and survival rates at the
end of follow-up timewere 98.6% and 93.1% respectively, which
is comparable to success and survival rates of implants placed in
native bone. In the series ofWu et al, 29 patients received a total
of 117 dental implants after reconstruction for oral tumor
surgery.60 In this study, the mean follow-up time was 47.8
months (range 24 to 84 months). The 1-year and 5-year
cumulative survival rate of the dental implants was 96% and
91%, respectively. The 1-year and5-year cumulative success rate
of the implants was 95% and 87%, respectively.
Failure of dental implants is mainly a result of infection,
tumor recurrence and soft-tissue proliferation.60 The fibula
free flap presents many advantages for implant placement,
but its limited height sometimes makes implant-supported
prosthetic rehabilitation difficult. A solution to that problem
could be the double barrel fibula free flap, to allow simulta-
neous reconstruction of the maxilla and the mandible.60,61
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